Furthermore, among patients with stomach cancer who were anti-HBc seropositive, the prevalence of HBV DNA positivity in cancer tissues was 54.5% in the Jiangsu cohort (12 of 22) and 54.3% in the Zhejiang cohort (19 of 35). The gene discussed is KRT88P; the disease is gastric cancer.